Literature DB >> 27634713

Ethical and Clinical Considerations at the Intersection of Functional Neuroimaging and Disorders of Consciousness.

Adrian C Byram, Grace Lee, Adrian M Owen, Urs Ribary, A Jon Stoessl, Andrea Townson, Judy Illes.   

Abstract

Recent neuroimaging research on disorders of consciousness provides direct evidence of covert consciousness otherwise not detected clinically in a subset of severely brain-injured patients. These findings have motivated strategic development of binary communication paradigms, from which researchers interpret voluntary modulations in brain activity to glean information about patients' residual cognitive functions and emotions. The discovery of such responsiveness raises ethical and legal issues concerning the exercise of autonomy and capacity for decisionmaking on matters such as healthcare, involvement in research, and end of life. These advances have generated demands for access to the technology against a complex background of continued scientific advancement, questions about just allocation of healthcare resources, and unresolved legal issues. Interviews with professionals whose work is relevant to patients with disorders of consciousness reveal priorities concerning further basic research, legal and policy issues, and clinical considerations.

Entities:  

Keywords:  brain injury; covert consciousness; informed consent; legal capacity; neuroethics; neuroimaging

Mesh:

Year:  2016        PMID: 27634713     DOI: 10.1017/S0963180116000347

Source DB:  PubMed          Journal:  Camb Q Healthc Ethics        ISSN: 0963-1801            Impact factor:   1.284


  2 in total

1.  Consciousness and Personhood in Medical Care.

Authors:  Stefanie Blain-Moraes; Eric Racine; George A Mashour
Journal:  Front Hum Neurosci       Date:  2018-08-02       Impact factor: 3.169

Review 2.  Empowering the voiceless. Disorders of consciousness, neuroimaging and supported decision-making.

Authors:  Timo Istace
Journal:  Front Psychiatry       Date:  2022-09-06       Impact factor: 5.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.